NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses

[1]  A. Zloza,et al.  Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+T cells and autoimmune vitiligo , 2011, Autoimmunity.

[2]  F. Pereyra,et al.  Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression. , 2011, Blood.

[3]  M. Posner,et al.  Development of Tumor-Infiltrating CD8+ T Cell Memory Precursor Effector Cells and Antimelanoma Memory Responses Are the Result of Vaccination and TGF-β Blockade during the Perioperative Period of Tumor Resection , 2011, The Journal of Immunology.

[4]  M. Nishimura,et al.  CD8 Co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression , 2011, Cancer Immunology, Immunotherapy.

[5]  R. Ahmed,et al.  From vaccines to memory and back. , 2010, Immunity.

[6]  S. Jameson,et al.  Diversity in T cell memory: an embarrassment of riches. , 2009, Immunity.

[7]  T. V. Van Belle,et al.  The role of the activating receptor NKG2D in autoimmunity. , 2009, Molecular immunology.

[8]  J. Schenkel,et al.  Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface. , 2009, Blood.

[9]  S. Jonjić,et al.  Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. , 2009, Immunity.

[10]  M. Tretiakova,et al.  Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15 , 2009, The Journal of experimental medicine.

[11]  P. Lehmann,et al.  The TRAIL of helpless CD8+ T cells in HIV infection. , 2008, AIDS research and human retroviruses.

[12]  B. Suarez-Alvarez,et al.  NKG2D ligands: key targets of the immune response. , 2008, Trends in immunology.

[13]  T. Waldmann,et al.  IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis , 2008, Proceedings of the National Academy of Sciences.

[14]  Surojit Sarkar,et al.  Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates , 2008, The Journal of experimental medicine.

[15]  P. Lehmann,et al.  Dissociated production of perforin, granzyme B, and IFN-gamma by HIV-specific CD8(+) cells in HIV infection. , 2008, AIDS research and human retroviruses.

[16]  E. Peterson,et al.  Adhesion and Degranulation-Promoting Adapter Protein (ADAP) Positively Regulates T Cell Sensitivity to Antigen and T Cell Survival1 , 2007, The Journal of Immunology.

[17]  A. Intlekofer,et al.  Brief Definitive Report , 2022 .

[18]  Nikhil S. Joshi,et al.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.

[19]  M. Bevan,et al.  Requirements for CD8 T-cell priming, memory generation and maintenance. , 2007, Current opinion in immunology.

[20]  N. Sheikh,et al.  Smart adjuvants , 2007, Expert review of vaccines.

[21]  R. Flavell,et al.  JNK2 negatively regulates CD8+ T cell effector function and anti‐tumor immune response , 2007, European journal of immunology.

[22]  J. Hopkins,et al.  The Effect of Gene Gun‐delivered pGM‐CSF on the Immunopathology of the Vaccinated Skin , 2007, Scandinavian journal of immunology.

[23]  J. Wolchok,et al.  Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. , 2006, The Journal of clinical investigation.

[24]  P. Leibson,et al.  NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells , 2006, Nature Immunology.

[25]  P. Doherty,et al.  Cell-mediated Protection in Influenza Infection , 2006, Emerging infectious diseases.

[26]  K. Schwarz,et al.  Recall Proliferation Potential of Memory CD8+ T Cells and Antiviral Protection1 , 2005, The Journal of Immunology.

[27]  Stephen P. Schoenberger,et al.  CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death , 2005, Nature.

[28]  Govind Bhagat,et al.  Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. , 2004, Immunity.

[29]  M. Bevan,et al.  CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection , 2004, Nature Immunology.

[30]  R. Koup,et al.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know , 2004, Nature Medicine.

[31]  Aaruni Khanolkar,et al.  Maintenance, Loss, and Resurgence of T Cell Responses During Acute, Protracted, and Chronic Viral Infections1 , 2004, The Journal of Immunology.

[32]  E. Wherry,et al.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.

[33]  Peter O. Krutzik,et al.  Intracellular phospho‐protein staining techniques for flow cytometry: Monitoring single cell signaling events , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[34]  Anthony M. Byers,et al.  Cutting Edge: Rapid In Vivo CTL Activity by Polyoma Virus-Specific Effector and Memory CD8+ T Cells1 , 2003, The Journal of Immunology.

[35]  L. Lanier,et al.  NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.

[36]  Hao Shen,et al.  Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory , 2003, Science.

[37]  R. Ahmed,et al.  CD8 T Cells Remember with a Little Help , 2003, Science.

[38]  M. Bevan,et al.  Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help , 2003, Science.

[39]  Urs Christen,et al.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.

[40]  A. Diefenbach,et al.  A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity , 2003, European journal of immunology.

[41]  D. Fremont,et al.  Cutting Edge: Murine UL16-Binding Protein-Like Transcript 1: A Newly Described Transcript Encoding a High-Affinity Ligand for Murine NKG2D1 , 2002, The Journal of Immunology.

[42]  B. Rocha,et al.  A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory , 2002, Science.

[43]  A. Diefenbach,et al.  The role of the NKG2D immunoreceptor in immune cell activation and natural killing. , 2002, Immunity.

[44]  P. Romero.  Faculty Opinions recommendation of NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. , 2002 .

[45]  Arthur I. Roberts,et al.  Cutting Edge: NKG2D Receptors Induced by IL-15 Costimulate CD28-Negative Effector CTL in the Tissue Microenvironment1 , 2001, The Journal of Immunology.

[46]  A. Diefenbach,et al.  Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.

[47]  S. Riddell,et al.  Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells , 2001, Nature Immunology.

[48]  R. Armitage,et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.

[49]  N. Shastri,et al.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.

[50]  T. Mcclanahan,et al.  Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. , 2000, Immunity.

[51]  M. O'gorman,et al.  Evaluation of TruCount Absolute-Count Tubes for Determining CD4 and CD8 Cell Numbers in Human Immunodeficiency Virus-Positive Adults , 2000, Clinical Diagnostic Laboratory Immunology.

[52]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[53]  T. Tabira,et al.  Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells , 1997, The Journal of experimental medicine.

[54]  D. Raulet,et al.  Natural killer cell receptors: The offs and ons of NK cell recognition , 1995, Cell.

[55]  R. Pitkin.  An embarrassment of riches. , 1989, Obstetrics and gynecology.

[56]  B. Su,et al.  The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. , 2007, Immunity.

[57]  Jelena S. Bezbradica,et al.  NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway , 2007, Nature Immunology.

[58]  藤井 俊策.  子宮 natural killer 細胞の測定意義 , 2006 .